The company is developing two manufacturing and developmentfacilities that will add just over 22,000 sf to its complex.
The firm said this week it has all but finished its 10,300-sfmanufacturing center. The building incorporates robotics technologyand is designed for the production of gene therapy products. Avigenplans to finish its second building, a 12,000-sf processdevelopment facility, in November.
The company reported increased losses of $15 million in Q2 dueto less grant funding, but has raised $75 million in privatefunding during fiscal 2000.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
